Related Experiment Videos
Usefulness of transstenotic coronary pressure gradient measurements during diagnostic catheterization
Insights
Measuring coronary pressure gradients helps assess the significance of moderate coronary artery narrowings. This aids in determining if patients with moderate stenoses will benefit from interventions like percutaneous transluminal coronary angioplasty.
Area of Science:
- Cardiovascular Medicine
- Interventional Cardiology
- Diagnostic Imaging
Background:
- Assessing the hemodynamic significance of moderate coronary stenoses (25-75% diameter narrowing) is challenging.
- Accurate assessment is crucial for guiding invasive therapies like percutaneous transluminal coronary angioplasty (PTCA) and coronary bypass surgery.
- Hemodynamic significance determines the need for intervention in patients with coronary artery disease.
Observation:
- Transstenotic coronary pressure gradients were measured in patients with moderate and severe coronary stenoses.
- Measurements utilized a specialized catheter system designed for optimal frequency response.
- Coronary blood flow was augmented using Renografin 76 to assess pressure gradients under high-flow conditions.
Findings:
- Mean transstenotic pressure gradients >10 mm Hg at rest or >20 mm Hg during high flow indicated myocardial ischemia.
- These pressure gradients correlated with symptomatic relief following PTCA.
- Smaller pressure gradients were observed in patients without ischemic symptoms.
Implications:
- Transstenotic pressure gradient measurement can aid clinical decision-making for moderate coronary stenoses.
- This technique provides objective data to complement angiographic assessment.
- It may help select appropriate candidates for revascularization procedures, optimizing patient outcomes.
Abstract:
A difficult problem in coronary arteriography is the assessment of the hemodynamic significance of stenoses that appear angiographically to be of only moderate severity (25 to 75% diameter narrowing). This is particularly important in patients who may be candidates for invasive therapy, such as percutaneous transluminal coronary angioplasty (PTCA) or coronary bypass surgery. To determine the significance of such lesions, we measured transstenotic coronary pressure gradients in 15 patients with angiographically moderate stenoses. For comparison, similar measurements were made in 17 patients with severe stenoses (more than 75% diameter narrowing) being considered for PTCA. The transstenotic pressure gradients were measured with a 2.0Fr polyvinyl chloride catheter cleared of microbubbles of air by flushing with carbon dioxide and degassed saline solution and attached to a low-volume displacement transducer for optimal frequency response. Mean transstenotic pressure gradients greater than 10 mm Hg at rest or more than 20 mm Hg under conditions of high coronary blood flow, as induced by Renografin 76, appeared to be associated with objective evidence of myocardial ischemia and symptomatic relief from PTCA. Smaller pressure gradients occurred in patients whose symptoms probably were not ischemic in nature. Transstenotic pressure gradient determination performed at the time of diagnostic catheterization may provide assistance in clinical decision-making in selected patients with angiographically moderate stenoses.